tradingkey.logo
tradingkey.logo
Search

Novavax Inc

NVAX
Add to Watchlist
7.320USD
-0.120-1.61%
Close 07-31 16:00ETQuotes delayed by 15 min
1.20BMarket Cap
LossP/E TTM

NVAX Financials

See Novavax Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Novavax Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.41
Revenue / Forecast
--/51.10M
Period
FY2025 Earnings
Revenue(YoY)
1.12B
64.69%
EPS(YoY)
2.72
320.62%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-101.81%-0.06
121.33%0.11
-64.48%-1.25
-39.93%0.66
405.38%3.22
64.88%-0.51
40.06%-0.76
68.59%1.09
69.09%-1.05
36.94%-1.44
---1.26
--0.65
---3.41
---2.28
---6.13
----
----
----
----
----
Revenue
-79.07%139.51M
66.61%147.14M
-16.64%70.44M
-42.42%239.24M
610.30%666.65M
-69.69%88.31M
-54.80%84.51M
-2.11%415.48M
15.94%93.86M
-18.48%291.34M
-74.55%186.99M
128.28%424.43M
-88.50%80.95M
60.85%357.40M
310.74%734.58M
-37.61%185.93M
57.41%703.97M
-20.55%222.20M
13.90%178.84M
738.59%298.02M
Net Profit
-101.83%-9.49M
121.63%17.53M
-66.84%-202.38M
-34.41%106.51M
451.51%518.65M
54.58%-81.03M
7.25%-121.30M
179.93%162.38M
49.80%-147.55M
2.12%-178.39M
22.44%-130.78M
111.36%58.01M
-244.49%-293.90M
78.46%-182.25M
47.71%-168.61M
-44.89%-510.49M
191.33%203.41M
-376.61%-846.28M
-63.41%-322.43M
-1910.83%-352.32M
Net Margin
-108.74%-6.80%
112.98%11.91%
-100.16%-287.29%
13.91%44.52%
149.49%77.80%
-49.85%-91.76%
-105.22%-143.53%
185.95%39.08%
56.70%-157.21%
-20.08%-61.23%
---69.94%
--13.67%
---363.07%
---50.99%
---29.28%
----
----
----
----
----
Gross Margin
-20.31%78.00%
43.92%84.98%
145.78%69.49%
5.17%93.59%
165.16%97.88%
26.14%59.04%
-39.97%28.27%
2.32%88.99%
-36.94%36.91%
-4.75%46.81%
--47.09%
--86.98%
--58.53%
--49.14%
--55.62%
----
----
----
----
----
Debt to assets ratio
59.94%28.28%
43.22%21.15%
56.23%21.29%
33.30%17.10%
4.38%17.68%
15.87%14.77%
1.65%13.62%
8.63%12.83%
31.31%16.94%
-47.64%12.74%
--13.40%
--11.81%
--12.90%
--24.34%
--19.32%
----
----
----
----
----
Revenue
-79.07%139.51M
66.61%147.14M
-16.64%70.44M
-42.42%239.24M
610.30%666.65M
-69.69%88.31M
-54.80%84.51M
-2.11%415.48M
15.94%93.86M
-18.48%291.34M
-74.55%186.99M
128.28%424.43M
-88.50%80.95M
60.85%357.40M
310.74%734.58M
-37.61%185.93M
57.41%703.97M
-20.55%222.20M
13.90%178.84M
738.59%298.02M
Operating profit
-101.94%-10.03M
116.69%20.94M
38.85%-79.38M
-34.81%105.67M
471.96%516.02M
31.64%-125.48M
-3.00%-129.82M
131.05%162.10M
55.57%-138.73M
24.73%-183.57M
0.91%-126.03M
114.53%70.16M
-249.19%-312.25M
70.44%-243.88M
58.59%-127.19M
-39.65%-482.96M
200.32%209.29M
-351.17%-824.97M
-58.37%-307.14M
-1931.06%-345.83M
Net Profit
-101.83%-9.49M
121.63%17.53M
-66.84%-202.38M
-34.41%106.51M
451.51%518.65M
54.58%-81.03M
7.25%-121.30M
179.93%162.38M
49.80%-147.55M
2.12%-178.39M
22.44%-130.78M
111.36%58.01M
-244.49%-293.90M
78.46%-182.25M
47.71%-168.61M
-44.89%-510.49M
191.33%203.41M
-376.61%-846.28M
-63.41%-322.43M
-1910.83%-352.32M
Current assets
-1.98%850.82M
-13.35%978.28M
-11.70%974.59M
-23.59%919.51M
19.38%868.03M
-1.31%1.13B
9.63%1.10B
6.72%1.20B
-25.12%727.12M
-32.85%1.14B
-42.80%1.01B
-47.21%1.13B
-58.63%971.03M
-20.96%1.70B
-19.05%1.76B
-9.30%2.14B
4.48%2.35B
72.66%2.16B
223.92%2.17B
270.06%2.35B
Total current liabilities
-18.88%342.46M
-60.16%459.95M
-63.60%429.87M
-66.39%389.14M
-47.52%422.17M
-29.40%1.15B
-19.58%1.18B
-27.47%1.16B
-58.08%804.38M
-33.53%1.64B
-11.95%1.47B
-25.97%1.60B
-15.13%1.92B
2.91%2.46B
-4.87%1.67B
30.56%2.16B
87.08%2.26B
312.36%2.39B
632.98%1.75B
674.16%1.65B
Total assets
-19.32%1.04B
-24.60%1.18B
-31.10%1.18B
-26.51%1.34B
-4.47%1.29B
-13.19%1.56B
3.34%1.71B
7.93%1.82B
-12.26%1.35B
-20.42%1.80B
-26.91%1.66B
-35.76%1.69B
-45.58%1.54B
-12.34%2.26B
-11.63%2.27B
-4.60%2.62B
8.68%2.83B
62.83%2.58B
171.81%2.57B
194.95%2.75B
Total liabilities
-13.20%1.19B
-40.29%1.30B
-40.30%1.34B
-42.28%1.30B
-38.37%1.37B
-13.13%2.18B
-4.14%2.24B
-7.76%2.25B
-8.93%2.22B
-13.08%2.51B
-17.57%2.34B
-19.75%2.44B
-11.96%2.44B
-1.22%2.89B
34.63%2.83B
51.69%3.04B
76.49%2.77B
206.55%2.93B
230.00%2.10B
265.78%2.00B
Total equity
-91.38%-144.76M
79.52%-127.75M
70.24%-156.67M
108.72%37.63M
91.28%-75.64M
12.98%-623.84M
22.39%-526.44M
42.78%-431.71M
3.18%-867.08M
-13.07%-716.93M
-19.85%-678.35M
-80.96%-754.52M
-1470.98%-895.58M
-80.30%-634.08M
-222.68%-565.99M
-155.92%-416.95M
-93.71%65.32M
-156.07%-351.67M
50.63%461.34M
93.98%745.56M
Net operating income
82.52%-32.42M
77.20%-39.48M
174.44%107.80M
-140.56%-127.46M
-122.01%-185.50M
2.05%-173.16M
-265.18%-144.81M
282.78%314.27M
74.34%-83.56M
-50.05%-176.78M
-2.45%-39.66M
-0.61%-171.94M
-267.86%-325.59M
65.59%-117.82M
72.77%-38.71M
-218.34%-170.90M
-113.35%-88.51M
-166.32%-342.41M
-2087.83%-142.14M
24.89%144.41M
Net investment
61.32%-28.36M
-85.78%20.48M
-527.83%-136.53M
129.81%111.10M
-911.30%-73.32M
1686.33%144.01M
273.52%31.91M
-4691.19%-372.71M
69.22%-7.25M
58.86%-9.08M
37.70%-18.39M
68.35%-7.78M
-40.01%-23.56M
-34.83%-22.06M
-142.16%-29.52M
-90.50%-24.58M
-111.88%-16.83M
47.42%-16.36M
87.90%-12.19M
93.15%-12.90M
Net financing
633.56%37.67M
-92.99%-6.60M
43854.64%42.44M
-100.40%-1.04M
-219.96%-7.06M
-103.41%-3.42M
-100.05%-97.00K
320.99%258.22M
101.66%5.89M
-47.56%100.39M
736.37%197.12M
1216.48%61.34M
-321.67%-354.38M
415.33%191.44M
-97.05%-30.98M
111.99%4.66M
-72.29%159.87M
-115.00%-60.71M
29.78%-15.72M
-109.32%-38.84M

FAQs

What is the total revenue of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its total revenue reached 1.12B, with a year-on-year change of 682.16M.

What are the current assets of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its current assets were 978.28M, with a year-on-year change of -13.35.

What are the total assets of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its total assets of Novavax Inc were 1.18B, with a year-on-year change of -24.60.

What are the total liabilities of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its total liabilities of Novavax Inc were 1.30B, with a year-on-year change of -40.29.

What is the total equity of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its total equity of Novavax Inc was -127.75M, with a year-on-year change of 79.52.

What is the net operating income of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its net operating income of Novavax Inc was 563.24M, with a year-on-year change of 342.85.

What is the net investment of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its net investment of Novavax Inc was -78.27M, with a year-on-year change of 61.64.

What is the net financing of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its net financing of Novavax Inc was 27.74M, with a year-on-year change of -89.36.

What is the Earnings Per Share (EPS) of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.72, with a year-on-year change of 320.62.

What is the net income of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its net income was 440.30M, with a year-on-year change of 334.83.

What is the net margin of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its net profit margin was 39.19, with a year-on-year change of 242.59.

What is the gross margin of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its gross margin was 93.50, with a year-on-year change of 32.76.

What is the debt-to-asset ratio of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its debt-to-asset ratio was 21.15, with a year-on-year change of 43.22.

What is the Return on Assets (ROA) of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its Return on Assets (ROA) was 32.17, with a year-on-year change of 388.11.

What is the operating profit of Novavax Inc?

According to Novavax Inc's FY2025 earnings report, its operating profit was 563.24M, with a year-on-year change of 342.85.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.